Some senators are voicing up their apprehensions regarding the
call to reevaluate the use of the controversial Dengvaxia vaccine.
For one Senate President Vicente Sotto III said questions regarding
the efficacy of Dengvaxia- manufactured
by Sanofi Pasteur and tested in the country remains to unresolved.
Sotto, call s for patience and the government should wait the
recommendations on the controversial vaccine before considering the use of the
product.
 |
| (photo credit to owner) |
“If it was not effective before, how can it be effective now?”
Sotto said. “It’s not that I’m not amenable, we all want protection from or
cure for dengue, but there is uncertainty in the product.”
The chairman of Blue Ribbon Committee, Sen. Richard Gordon that investigated the Dengvaxia controversy in the last Congress (17th),
said releasing the vaccine to the market for use would be a “catastrophic step
in the wrong direction.”
Gordon said when the Blue Ribbon committee probed the P3.5-billion
procurement of the vaccines in 2016, the senators found “a lot of ethical
things happening,” including meetings between then president Benigno Aquino III
and former health secretary Janet Garin with Sanofi-Pasteur executives.
Gordon also revealed that he wrote a letter to Department of Health(DOH)
Secretary Francisco Duque III two weeks ago requesting him to check on whether
those inoculated with the vaccine got sick again with dengue.
Share us your thoughts by simply
leaving on the comment section below. For more news updates, feel free to visit
our site often.
Stay updated with today's relevant
news and trends by hitting the LIKE button.
Thanks for dropping by and reading
this post.
Report from PhiStar
0 Comments